science

Dear Research Advocate, Sandy was a terrifying October surprise. The devastation in New York and New Jersey is extensive, and it will take a long time to rebuild and to heal. It’€™s a reminder that not everything is about the election. That said, it is impossible not to think about a major election theme ’€” the role of government ’€” and also to think about climate change, one of many science topics not being discussed in this election season. Yet decisions involving the future of science will be made by those elected. That’€™s why we need to turn up the advocacy volume as loud as possible after the election, when the lame-duck Congress and the administration, closely watched and...
Dear Research Advocate, If we cut back our investments in science and research, we will lose out on the companies and innovation that come with it. That was the message President Obama delivered Tuesday night during the second presidential debate. Governor Romney mentioned the wisdom of keeping STEM graduates in the U.S. by ’€œstapling a green card’€ to their diplomas. In addition, Governor Romney responded to our Your Candidates ’€“ Your Health voter education initiative with a statement that stresses his commitment to ensuring government plays a role in supporting life sciences research and asserting that medical innovation must be a national priority. Please share both Governor Romney...
We extend our deepest condolences to Senator Arlen Specter’s family, friends and colleagues as they mourn the passing of a loved and respected statesman and a true champion of medical research. Specter’s leadership in generating critical support for medical and health research is a testament to his dedication to improving the health of all Americans and securing our position as a global leader in science and innovation. As a congressional leader, Specter played a pivotal role in the doubling of the National Institutes of Health (NIH) budget over five years and two Administrations and in 2009 assured that funding for the NIH and other health agencies were included in the American Recovery...
Dear Research Advocate, This week’€™s Nobel Prize announcements are a fine reminder of how government-supported research plays a critical role in expanding our knowledge, leading not only to worldwide recognition but taking us closer to understanding and curing disease. The winners of the prize for chemistry, Dr. Robert Lefkowitz, Howard Hughes Medical Research investigator and professor at Duke University Medical Center, and Dr. Brian Kobilka of Stanford University School of Medicine both received grants from the National Institutes of Health, as did one of the physiology and medicine awardees, Dr. Shinya Yamanaka. They are among the many Nobel laureates whose important work throughout the...
October 3, 2012 The first Presidential debate was a missed opportunity for the candidates to outline a vision for putting research and innovation to work to improve health and strengthen the economy. Fleeting references to science and research failed to give voters confidence in this regard. We learned some things in this debate, but we are still — many of us literally — dying to know what either candidate will do to assure that research for health will be a priority for this nation. Without medical progress, driven by research and innovation, there will be no chance of controlling health care costs or assuring our nation’s continued leadership in the life sciences. We strongly urge the...
National Institutes of Health Director Francis Collins, MD, PhD , and a Research!America Board member, former Congressman Mike Castle , will appear on BioCenturyTV during the next two weeks to discuss declines in federally funded research. “BioCentury This Week” airs at 8:30 a.m. Sundays on WUSA-9 in the Washington, DC, area. In other areas, the program is available on the show’s website at www.biocenturytv.com . The September 23 show will feature Collins, who will discuss sequestration, NIH grant rates, ways to reduce the costs of clinical trials and the NIH’s public-private partnerships. The September 30 show will feature Castle; Daniel Ford, MD, MPH , vice dean for clinical investigation...
Dear Research Advocate, To call attention to the unintended consequences of the sequester, we held a press briefing today in partnership with United for Medical Research. Two Members of Congress who are still in town, Reps. Ed Markey (D-MA) and Brian Bilbray (R-CA), spoke about the high priority the nation must place on NIH and about the usefulness of data from a new national public opinion poll showing that 51% of Americans say that across-the-board cuts are not the right way to reduce the deficit. To see more poll results for use in your advocacy, click here . Other speakers this morning spoke about what’€™s at stake for everyone who cares about the research enterprise: patient hopes for...
Dear Research Advocate, American achievement continues to astound. This week we watched NASA’€™s Jet Propulsion Laboratory send one of the most advanced space exploration vehicles ever constructed to a planet hundreds of millions of miles away from Earth and elegantly deliver it to the planet’€™s surface. Mars today, why not a cure for our nation’€™s deadliest diseases tomorrow? As advocates, we cannot take no for answer when it comes to assuring we have the resources, policies and determination we need to defeat disease and disability. Why should we be reluctant to demand that this be a national priority? As Margaret Mead once said, ’€œNever doubt that a small group of thoughtful,...

Pages